Copertina

Molecularly Informed Combination Therapy for BRAF‐KIAA1549 Fusion‐Positive Pilocytic Astrocytoma in a Resource‐Limited Setting

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autore principale:	Yousef VatanParast
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Pediatric Blood & Cancer
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Pseudoprogression in Pediatric Spinal Pilocytic Astrocytoma and Myxopapillary Ependymoma after Proton Therapy: A Case Series
di: Kamaria L. Lee, et al.
Pubblicazione: (2025)

Inclusion of Optic Pathway and Hypothalamic Tumors in Prognostic Studies of Pilocytic Astrocytoma: Is It Justified?
di: Qingtian Liang, et al.
Pubblicazione: (2025)

FGFR1:TACC1 ‐Fused Pilocytic Astrocytoma in a Child With Muenke Syndrome: A Case Report
di: Veda Malhotra, et al.
Pubblicazione: (2026)

Examining the Impact of Time‐to‐Treatment on Disease‐Specific Survival in Pediatric Pilocytic Astrocytoma: A Multi‐Institutional Retrospective Cohort Analysis
di: Anisha Kohli, et al.
Pubblicazione: (2025)

Sustained Remission in a Pediatric B‐Cell Acute Lymphoblastic Leukemia With Rare PAX5::KIAA1549L Fusion and Complex Karyotype Following Blinatumomab Consolidation
di: Xiaoyong Chen, et al.
Pubblicazione: (2025)

Pediatric High‐Grade Astrocytoma With Piloid Features: A Comprehensive Literature Review
di: Danae Kokossis, et al.
Pubblicazione: (2026)

Real‐World Chemoport Outcomes in Pediatric Oncology in a Resource‐Limited Setting: A Retrospective Analysis With Pragmatic Implications
di: Soumitra Saha, et al.
Pubblicazione: (2025)

Cerebrospinal Fluid Liquid Biopsy Enables Targeted Therapy Without Tissue Diagnosis in Pediatric Low‐Grade Gliomas With BRAF V600E Mutation
di: Hannah Sultan, et al.
Pubblicazione: (2026)

Expansion of the Phenotype of Lymphatic Anomalies Caused by Somatic Activating BRAF Variant
di: Michael D. Fox, et al.
Pubblicazione: (2025)

Rare EWSR1::PBX1 Fusion‐Positive Infant B‐ALL With Coexisting KRAS Mutation: Sustained Molecular Remission Achieved With Standard Chemotherapy
di: Xiaoyong Chen, et al.
Pubblicazione: (2025)

Comment on: “Challenging the Odds: Long‐Term Survival in Pediatric Diffuse Midline Glioma With H3 K27M and BRAF V600 Co‐Mutations Treated With Upfront Radiotherapy and Targeted Therapy”
di: Natália Dassi, et al.
Pubblicazione: (2026)

BRAF/MEK inhibitors use to treat ventriculoperitoneal shunt‐associated ascites in pediatric low‐grade gliomas
di: Nisreen Amayiri, et al.
Pubblicazione: (2024)

Access Program for Unapproved and Off‐Label Drug Use in Pediatric BRAF V600E‐Mutated Brain Tumors in Japan
di: Maya Suzuki, et al.
Pubblicazione: (2025)

Sustained Remission Off‐Therapy in a Case of Infantile ALK‐Positive Multisystem Histiocytosis Treated With Crizotinib
di: Saba Azarnoush, et al.
Pubblicazione: (2025)

Activity of the MEK inhibitor trametinib in a patient with a BRAF mutation persisting from T‐lymphoblastic lymphoma through lineage switch to CNS acute myeloid leukemia
di: Wallace Bourgeois, et al.
Pubblicazione: (2024)

Disseminated DIG–DIA With a Rare FMR1–RAF1 Fusion With Good Response to Targeted Therapy
di: Laurence Reeves‐Breton, et al.
Pubblicazione: (2024)

Ocular Safety and Visual Acuity Stability in Pediatric Patients With Optic Pathway Gliomas and Orbital Plexiform Neurofibromas Treated With BRAF and MEK Inhibitors
di: Aviv Sever, et al.
Pubblicazione: (2025)

Preemptive Versus Empirical Antifungal Therapy for High‐Risk, Febrile, Neutropenic Solid Tumor Patients in an LMIC Setting
di: Omnia Al‐Qadi, et al.
Pubblicazione: (2025)

BRAF‐V600E mutations in plasma and peripheral blood mononuclear cells correlate with prognosis of pediatric Langerhans cell histiocytosis treated with first‐line therapy
di: Chan‐Juan Wang, et al.
Pubblicazione: (2024)

Rapid remission of life‐threatening chylo‐ascites with dabrafenib and trametinib combination in complex lymphatic anomaly with pathogenic somatic BRAF and PIK3CA co‐variation
di: Mathias Yuan, et al.
Pubblicazione: (2024)

A Rare Case of Pediatric BRAF V600E‐Mutated Erdheim–Chester Disease With Isolated Central Nervous System Onset: Diagnosis, Treatment, and Efficacy Evaluation
di: Jing Ni, et al.
Pubblicazione: (2026)

A Unique Presentation of Early‐Onset Colon Cancer in the Setting of Helicobacter pylori Positivity, IgA Deficiency, and a Germline 18p Deletion
di: Kelsey Gay, et al.
Pubblicazione: (2025)

Highlighting Healthcare Disparities in Sickle Cell Disease Management in Resource‐Constrained Settings: A Cross‐Sectional Study in Lebanon
di: Morgan Bou Zerdan, et al.
Pubblicazione: (2025)

TCF3::HLF Fusion Gene in a Pediatric B‐Cell Lymphoblastic Lymphoma With Multifocal Osteolytic Lesions: Expanding the Clinical and Molecular Landscape
di: Markéta Racková, et al.
Pubblicazione: (2025)

Pediatric B‐Cell Acute Lymphoblastic Leukemia With FUS::FLI1 Fusion in an Infant With Measurable Residual Disease: Sustained Molecular Remission Achieved With Blinatumomab
di: Qiang Yao, et al.
Pubblicazione: (2025)

Clinical Characteristics and Prognostic Analysis of Non‐ NPM1‐ALK Fusions in Pediatric Patients With ALK‐Positive Anaplastic Large‐Cell Lymphoma: A Single‐Center Retrospective Study in China
di: Ting Zhu, et al.
Pubblicazione: (2025)

A Rare Case of Infant B‐ALL With SIN3A::NUTM1 Fusion: Durable Molecular Remission Achieved With Standard Acute Lymphoblastic Leukemia Chemotherapy
di: Dong Peng, et al.
Pubblicazione: (2026)

Treatment of Pediatric, Adolescent, and Young Adult Patients With Fusion‐Positive Alveolar Rhabdomyosarcoma Infiltrating Regional Lymph Nodes in the European CWS‐2002P and RMS 2005 Studies and the Soft Tissue Sarcoma Registry
di: Amadeus T. Heinz, et al.
Pubblicazione: (2024)

Use of Oral Metformin Therapy for Therapy‐Induced Hyperglycemia in Pediatric Patients With Acute Lymphoblastic Leukemia
di: Ankita Chakraborty, et al.
Pubblicazione: (2026)

Proton Therapy for Locally Advanced Unresectable Ameloblastoma in a Child
di: Amanda Acevedo, et al.
Pubblicazione: (2025)

Therapy‐Associated Polyposis in Pediatric Cancer Survivors
di: Sue L. Jaspersen, et al.
Pubblicazione: (2026)

Soft Tissue Undifferentiated Sarcoma Carrying a Novel Onecut1::Nutm1 Fusion
di: Maria Filippidou, et al.
Pubblicazione: (2024)

Tumor‐Specific Critical Intraoperative Findings Influence Multidisciplinary Therapy
di: Abdelhafeez Abdelhafeez, et al.
Pubblicazione: (2025)

BCG Infection Following Therapy of Infant Acute Lymphoblastic Leukemia
di: Mikhail Lemeshev, et al.
Pubblicazione: (2026)

Dermatofibrosarcoma Protuberans in Infancy: Targeted Therapy Facilitating Complete Resection
di: Aditi Tulsiyan, et al.
Pubblicazione: (2026)

Management of Philadelphia Chromosome‐Positive B‐Lymphoblastic Leukemia Diagnosed in an Infant
di: Jessica A. O. Zimmerman, et al.
Pubblicazione: (2025)

Increasing Rate of Unfilled Training Positions in the Pediatric Hematology Oncology Match
di: Jason Silvestre
Pubblicazione: (2025)

Treatment of Intermediate‐Risk Hepatoblastoma Using a Combined Cisplatin and Doxorubicin (PLADO) Regimen and Optimized Surgical Resection
di: Tomoro Hishiki, et al.
Pubblicazione: (2025)

Hydroxyurea Therapy and Sleep‐Disordered Breathing in Children With Sickle Cell Disease
di: Zachary Abramson, et al.
Pubblicazione: (2025)

Pazopanib Combined With Vincristine and Irinotecan in Relapsed Wilms Tumor: Encouraging Outcomes in a Heavily Pretreated Pediatric Cohort
di: Maria Debora De Pasquale, et al.
Pubblicazione: (2026)